secwatch.observer — SEC 8-K summary
======================================

Issuer:     Alaunos Therapeutics, Inc. (TCRT)
CIK:        0001107421
Form:       8-K
Filed at:   2025-05-23T23:59:59+00:00
Accession:  0000950170-25-077064
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Alaunos Therapeutics enters $25M equity purchase agreement with Mast Hill Fund
------------------------------------------------------------------------------

- Mast Hill commits to buy up to $25M of common stock over 24 months at Company's discretion.
- Company issued warrant to Mast Hill for 79,900 shares at $4.00 exercise price, 5-year term.
- Minimum put $5K, max $500K per put or 20% of 5-day avg trading volume.
- Shares subject to 4.99% beneficial ownership cap and Nasdaq 19.99% exchange cap unless stockholder approval.
- Registration rights agreement requires filing registration statement within 60 days.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1107421/000095017025077064/0000950170-25-077064-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1107421/000095017025077064/tcrt-20250519.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-077064

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer